We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Perception Prognosis, Goals of Treatment, and Communication

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01401894
Recruitment Status : Completed
First Posted : July 25, 2011
Last Update Posted : January 31, 2017
Sponsor:
Information provided by (Responsible Party):
El-Jawahri, Areej,M.D., Massachusetts General Hospital

Brief Summary:
The purpose of this research study is to assess what the participant understands about their illness, prognosis, the goals of the cancer treatment and their communication with their oncology providers. This study will help us to figure out how the investigators can improve how other patients understand their illness and goals of treatment and help us improve communication with their doctors. This research is being done because there is not a lot of information on how much patients understand about their illness and prognosis.

Condition or disease
Gastric Cancer Esophageal Cancer Pancreatic Cancer Liver Cancer Biliary Cancer

Detailed Description:
  • Participants will be asked to answer a few basic questions regarding race, ethnicity, religion, relationship status, education, income, and living situation.
  • They will then be asked to complete a questionnaire which contains questions about their mood, spirituality, quality of life and their understanding of their treatment and prognosis and their communication with their oncologist. They will complete these questionnaires in the clinic or infusion room on one of their regularly scheduled visit.

Study Type : Observational
Actual Enrollment : 50 participants
Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: Pilot Study to Investigate Advanced Cancer Patient's Perspective of Their Prognosis, Goals of Treatment, and Quality of Communication With Their Oncologists
Study Start Date : October 2010
Primary Completion Date : October 2012
Study Completion Date : June 2014





Primary Outcome Measures :
  1. Completion of surveys [ Time Frame: 1 year ]

Secondary Outcome Measures :
  1. Patients perceptions of prognosis, goals of care, and communication with providers [ Time Frame: 1 year ]
  2. Quality of end of life care [ Time Frame: 1 year ]
  3. Survival [ Time Frame: 1 year ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All patients with a recent diagnosis of advanced gastric, esophageal, pancreatic and hepatobiliary cancer, not being treated with curative intent and receiving their cancer care at Massachusetts General Hospital.
Criteria

Inclusion Criteria:

  • Confirmed new diagnosis of advanced gastric, esophageal, pancreatic, and hepatobiliary cancer, not being treated with curative intent.
  • Planning to receive chemotherapy at Massachusetts General Hospital
  • Ability to read and respond to questions in English.

Exclusion Criteria:

  • Prior chemotherapy for current stage of disease.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01401894


Locations
United States, Massachusetts
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
Sponsors and Collaborators
Massachusetts General Hospital
Investigators
Principal Investigator: Jennifer Temel, MD Massachusetts General Hospital

Responsible Party: El-Jawahri, Areej,M.D., Director MGH BMT Survivorship Program, Massachusetts General Hospital
ClinicalTrials.gov Identifier: NCT01401894     History of Changes
Other Study ID Numbers: 10-219
First Posted: July 25, 2011    Key Record Dates
Last Update Posted: January 31, 2017
Last Verified: January 2017

Keywords provided by El-Jawahri, Areej,M.D., Massachusetts General Hospital:
advanced cancer

Additional relevant MeSH terms:
Pancreatic Neoplasms
Stomach Neoplasms
Esophageal Neoplasms
Liver Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Neoplasms
Endocrine Gland Neoplasms
Digestive System Diseases
Pancreatic Diseases
Endocrine System Diseases
Gastrointestinal Neoplasms
Gastrointestinal Diseases
Stomach Diseases
Head and Neck Neoplasms
Esophageal Diseases
Liver Diseases